Innogenetics NV - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Innogenetics NV. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Innogenetics NV. The Group's principal activities are to provide diagnostic and therapeutic products using biotechnological research. The Diagnostics business focuses on infectious diseases, genetic testing, and neurodegeneration of many common diseases like HIV, Syphilis, Mycobacteria, Alzheimer's disease, HLA Class I and II etc. The Therapeutics division develops vaccines for infectious diseases for which current treatment options are limited. Their products include vaccines for Hepatitis B, Hepatitis C, Pulmonary Edema and other hard-to-heal wounds. The Group has operations in the United States, Germany, Spain, Italy, France, Brazil and the United Kingdom.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report